[{"id":"5218358d-3cd5-46b6-ae09-f982edd390ee","acronym":"","url":"https://clinicaltrials.gov/study/NCT02077777","created_at":"2021-01-18T09:34:37.178Z","updated_at":"2024-07-02T16:37:27.321Z","phase":"Phase 2","brief_title":"Chemopreventive Action of Mesalazine on Colorectal Cancer: a Pilot Study for an \"in Vivo\" Evaluation of the Molecular Effects on β-catenin Signaling Pathway.","source_id_and_acronym":"NCT02077777","lead_sponsor":"SOFAR S.p.A.","biomarkers":" MYC • CCND1 • CEBPA • KLF4 • CASP3 • TCF7L2 • CDH2 • CDKN1A • CDH23 • TCF4","pipe":" | ","alterations":" CCND1 expression","tags":["MYC • CCND1 • CEBPA • KLF4 • CASP3 • TCF7L2 • CDH2 • CDKN1A • CDH23 • TCF4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CCND1 expression"],"overall_status":"Completed","enrollment":" Enrollment 21","initiation":"Initiation: 10/01/2012","start_date":" 10/01/2012","primary_txt":" Primary completion: 06/01/2016","primary_completion_date":" 06/01/2016","study_txt":" Completion: 06/01/2016","study_completion_date":" 06/01/2016","last_update_posted":"2016-12-02"}]